Skip to content
GCC AI Research

Technology Innovation Institute, Burjeel Medical City Partner to Advance Immunotherapy Solutions for Cancer Patients

TII · · Significant research

Healthcare Research Partnership Ethics Funding

Summary

Technology Innovation Institute (TII) and Burjeel Medical City (BMC) are partnering to develop novel immunotherapy solutions for cancer treatment, focusing on T-cell based therapeutics like CAR-T and TIL therapy. In the first phase, TII will construct a computational platform to identify patient-specific antigens from single-cell transcriptomics data, enabling the design of CAR-T cells. The two-year partnership aims to boost the body's immune system to fight cancer and personalize cancer therapies using TII's technologies. Why it matters: This collaboration signifies the UAE's commitment to advancing cancer care through collaborative research and innovative solutions, potentially establishing the country as a leader in personalized oncology treatments.

Keywords

Immunotherapy · Cancer · CAR-T · TIL · TII

Read original article →

Get the weekly digest

Top AI stories from the GCC region, every week.

Related

Technology Innovation Institute Unveils 2 µm Fiber Laser for Medical and Industrial Use

TII ·

The Technology Innovation Institute (TII) in Abu Dhabi has launched a 2-micrometer high-power fiber laser for medical and industrial applications. Developed by TII's Directed Energy Research Center, the Thulium-based laser is efficient, compact, and scalable, enabling precise interaction with water-rich materials. TII has partnered with LIMA Photonics, a German MedTech startup, to integrate the laser into clinical solutions, including urinary stone treatment and prostate surgery. Why it matters: This laser technology and partnership showcase the UAE's commitment to translating advanced research into healthcare solutions, positioning Abu Dhabi as a hub for medical technology innovation.

Technology Innovation Institute Launches Cutting-Edge Biofoundry to Advance R&D in Synthetic Biology

TII ·

The Technology Innovation Institute (TII) in Abu Dhabi has launched a Biofoundry to advance R&D in synthetic biology, focusing on genetic engineering, metabolic engineering, and bioinformatics. The facility features high-throughput robotic systems, next-generation sequencing, and advanced computational tools. TII's Biofoundry is now part of the Global Biofoundry Alliance (GBA) to foster partnerships and address shared challenges. Why it matters: This initiative positions the UAE as a key player in synthetic biology, with potential breakthroughs across healthcare, agriculture, and environmental sustainability.